Historically, patient-reported outcome measures were primarily utilized for research purposes in orthopedics.However, renewed ...

ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, dryness, and daily function often drive patients' quality of life and may ...

Primary labral repair of the hypoplastic labrum may be a viable treatment option for adults with femoroacetabular impingement ...

Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

Using Music as a Tool for Distress Reduction During Cancer Chemotherapy Treatment Future work should aim to improve patient adherence to remote patient-reported outcome and activity data collection ...

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...

When doctors and insurers want to evaluate a patient’s health status, they typically use objective and broad measures, such as laboratory and vital sign measures like blood pressure or hemoglobin A1c, ...